In mice with diet-induced obesity, a single dose of recombinant Fgf21 is sufficient to improve insulin sensitivity and glucose disposal, and chronic administration promotes body weight loss and reduced adiposity (16, 23). The gene discussed is FGF21; the disease is obesity disorder.